Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BeOne Medicines Ltd.ONC · Entity 2168 | SVP, General Counsel | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BeOne Medicines Ltd.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-09-30 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-30 · Sale · Disposed 1,115 · Balance 0 F2: Each American Depositary Share represents 13 Ordinary Shares. F3: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 311,324 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 311,324 F1: Includes 507 ordinary shares acquired pursuant to the Company's 2018 Employee Share Purchase Plan, as amended from time to time. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 507 ordinary shares acquired pursuant to the Company's 2018 Employee Share Purchase Plan, as amended from time to time.
F2: Each American Depositary Share represents 13 Ordinary Shares.
F3: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2026 Filed Mar 11, 2026 00:13 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantOrdinary Shares | 29,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001980648-26-000005 · wk-form4_1773188022.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,370 F2 · shares: Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2028, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| March 06, 2026 Filed Mar 11, 2026 00:13 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantOrdinary Shares | 65,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001980648-26-000005 · wk-form4_1773188022.xml · nonDerivative · entry 1 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,496 F1 · shares: Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2027, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:57 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 6,448 | $0.00 Strike: $12.23 | $0.00 |
DisclosureSEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · derivative · entry 9 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,670 Underlying: Ordinary Shares · 6,448 shares Expires 2034-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:57 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 8,606 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · derivative · entry 8 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,413 Underlying: Ordinary Shares · 8,606 shares Expires 2033-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F5 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:57 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 6,526 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · derivative · entry 7 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,920 Underlying: Ordinary Shares · 6,526 shares Expires 2032-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:57 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 996 | $350.00 | $348,600.00 |
DisclosureSEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · nonDerivative · entry 6 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:57 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 664 | $348.79 | $231,596.56 |
DisclosureSEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · nonDerivative · entry 5 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 996 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:57 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 496 | $159.03 | $78,878.88 |
DisclosureSEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · nonDerivative · entry 4 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:57 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 662 | $213.32 | $141,217.84 |
DisclosureSEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · nonDerivative · entry 3 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:57 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 502 | $194.47 | $97,623.94 |
DisclosureSEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:15 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 2,548 | $0.00 Strike: $12.23 | $0.00 |
DisclosureSEC source: 0001980648-26-000002 · wk-form4_1767996952.xml · derivative · entry 8 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,118 Underlying: Ordinary Shares · 2,548 shares Expires 2034-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:15 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 3,458 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001980648-26-000002 · wk-form4_1767996952.xml · derivative · entry 7 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,019 Underlying: Ordinary Shares · 3,458 shares Expires 2033-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F5 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:15 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 2,626 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001980648-26-000002 · wk-form4_1767996952.xml · derivative · entry 6 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,446 Underlying: Ordinary Shares · 2,626 shares Expires 2032-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:15 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 664 | $331.76 | $220,288.64 |
DisclosureSEC source: 0001980648-26-000002 · wk-form4_1767996952.xml · nonDerivative · entry 5 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:15 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 196 | $159.03 | $31,169.88 |
DisclosureSEC source: 0001980648-26-000002 · wk-form4_1767996952.xml · nonDerivative · entry 4 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:15 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 266 | $213.32 | $56,743.12 |
DisclosureSEC source: 0001980648-26-000002 · wk-form4_1767996952.xml · nonDerivative · entry 3 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:15 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 202 | $194.47 | $39,282.94 |
DisclosureSEC source: 0001980648-26-000002 · wk-form4_1767996952.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 1,274 | $0.00 Strike: $12.23 | $0.00 |
DisclosureSEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · derivative · entry 15 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,666 Underlying: Ordinary Shares · 1,274 shares Expires 2034-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 1,729 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · derivative · entry 14 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,477 Underlying: Ordinary Shares · 1,729 shares Expires 2033-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F5 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 1,313 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · derivative · entry 13 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,072 Underlying: Ordinary Shares · 1,313 shares Expires 2032-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 332 | $325.00 | $107,900.00 |
DisclosureSEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 9 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 98 | $159.03 | $15,584.94 |
DisclosureSEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 8 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 133 | $213.32 | $28,371.56 |
DisclosureSEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 7 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 101 | $194.47 | $19,641.47 |
DisclosureSEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 6 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 1,274 | $0.00 Strike: $12.23 | $0.00 |
DisclosureSEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · derivative · entry 12 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,940 Underlying: Ordinary Shares · 1,274 shares Expires 2034-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 1,729 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · derivative · entry 11 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,206 Underlying: Ordinary Shares · 1,729 shares Expires 2033-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F5 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 1,313 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · derivative · entry 10 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,385 Underlying: Ordinary Shares · 1,313 shares Expires 2032-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 332 | $318.28 | $105,668.96 |
DisclosureSEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 5 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 98 | $159.03 | $15,584.94 |
DisclosureSEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 4 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 133 | $213.32 | $28,371.56 |
DisclosureSEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 3 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 101 | $194.47 | $19,641.47 |
DisclosureSEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:28 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 3,848 | $0.00 Strike: $12.23 | $0.00 |
DisclosureSEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · derivative · entry 9 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,214 Underlying: Ordinary Shares · 3,848 shares Expires 2034-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:28 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 5,174 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · derivative · entry 8 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,935 Underlying: Ordinary Shares · 5,174 shares Expires 2033-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F5 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:28 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 3,926 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · derivative · entry 7 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,698 Underlying: Ordinary Shares · 3,926 shares Expires 2032-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:28 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 332 | $350.00 | $116,200.00 |
DisclosureSEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · nonDerivative · entry 6 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:28 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 664 | $348.75 | $231,570.00 |
DisclosureSEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · nonDerivative · entry 5 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 332 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:28 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 296 | $159.03 | $47,072.88 |
DisclosureSEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · nonDerivative · entry 4 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:28 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 398 | $213.32 | $84,901.36 |
DisclosureSEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · nonDerivative · entry 3 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:28 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 302 | $194.47 | $58,729.94 |
DisclosureSEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 20:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 3,848 | $0.00 Strike: $12.23 | $0.00 |
DisclosureSEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · derivative · entry 11 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 127,062 Underlying: Ordinary Shares · 3,848 shares Expires 2034-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F8 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 20:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 116,493 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · derivative · entry 10 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,109 Underlying: Ordinary Shares · 116,493 shares Expires 2033-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F7 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 20:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 3,926 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · derivative · entry 9 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,624 Underlying: Ordinary Shares · 3,926 shares Expires 2032-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 20:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 4,162 | $351.12 | $1,461,374.76 |
DisclosureSEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · nonDerivative · entry 8 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.00 to $351.53, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 20:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 4,733 | $350.22 | $1,657,580.37 |
DisclosureSEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · nonDerivative · entry 7 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,162 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 20:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 664 | $347.82 | $230,952.48 |
DisclosureSEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · nonDerivative · entry 6 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,895 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 20:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 296 | $159.03 | $47,072.88 |
DisclosureSEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · nonDerivative · entry 5 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 20:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 8,961 | $213.32 | $1,911,560.52 |
DisclosureSEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · nonDerivative · entry 4 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 20:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 302 | $194.47 | $58,729.94 |
DisclosureSEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · nonDerivative · entry 3 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 20:56 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 1,112 | $350.00 | $389,200.00 |
DisclosureSEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 3,848 | $0.00 Strike: $12.23 | $0.00 |
DisclosureSEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · derivative · entry 12 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,910 Underlying: Ordinary Shares · 3,848 shares Expires 2034-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F8 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.